GTC is proud to present its 10th Annual Vaccines Discovery and Development: All Things Considered conference, to be held in San Francisco, CA on July 9-10, 2012. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, manufacturing, regulations, investment, and policy, in a comfortable, interactive, and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.
Development of new vaccines truly requires a consideration of all things. We examine vaccine development from basic research to marketing. We bring together researchers, manufacturers, executives, investors and government officials to interact and share their perspectives of the vaccine industry. We will also be discussing hot topics like Vaccines for Emerging Markets in Developing Worlds with a global perspective from academia and industry. Representatives from the HHS, BARDA, CDC and DARPA will provide a first-hand perspective into current US vaccines policy, regulation and funding as well as updates on the pandemic and bio-defense policy.